Forsiden ENOVA

Group photo from 2nd enova workshop

ENOVA is a science and technology “Network on Vaccine Adjuvants”, funded by COST through the EU Framework Programme Horizon 2020. ENOVA is coordinated by the Vaccine Formulation Institute (UK) and brings together European experts and stakeholders working in different areas of adjuvant and vaccine R&D, including both prophylactic and therapeutic applications as well as human and veterinary vaccines.  ENOVA’s members include industry, academic, and government institutions. The ultimate goals of the network are to facilitate communication and the exchange of information among its membership, to ensure that new discoveries are widely disseminated so that their potential can be of optimal benefit, to promote the best use of existing adjuvant technologies, and to encourage and support the development of novel adjuvants.

Log in (restricted)

News

  • Virtual Networking Grants May 21, 2021 10:58 AM

    COST has launched Virtual Networking Support and there are two options available:

  • live_logo LIVE Master in Vaccinology Dec. 2, 2020 11:22 AM

    Leading Interational Vaccinology Education

    A Programme of Excellence in Learning and Research, Looking for Biochemists, Bioengineers, Biologists, Clinicians, Pharmacists and Veterinarians

  • transvac2-tna2010-10-social-media-banner Transvac call Nov. 6, 2020 11:58 AM

    Open Call: Apply for TRANSVAC2 Vaccine Development Services

  • review_fig2 Review article on adjuvants Sep. 4, 2020 9:17 AM

    ENOVA partners publish review article on the use of adjuvants to boost therapeutic vaccines

Events

01 Sep.
Belgrade, Serbia

6th European Congress of Immunology in Belgrade, Serbia

1-4 September 2021

For more information